Sodium glucose cotransport-2 inhibition and intrarenal RAS activity in people with type 1 diabetes

Affiliations

¹ Division of Nephrology, Department of Medicine, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada.
² Division of Endocrinology, Department of Medicine, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada.
³ Boehringer Ingelheim Canada Ltd/Ltée, Burlington, Ontario, Canada.
⁴ Kidney Research Centre, Division of Nephrology, Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
⁵ Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.
⁶ Boehringer Ingelheim Norway KS, Asker, Norway.
⁷ Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut, USA.

PMID: 25360497
DOI: 10.1038/ki.2014.246

Free article

Comment

Sodium glucose cotransport-2 inhibition and intrarenal RAS activity in people with type 1 diabetes

David Z I Cherney et al. Kidney Int. 2014 Nov.

Free article

. 2014 Nov;86(5):1057-8.

doi: 10.1038/ki.2014.246.

Authors

Affiliations

¹ Division of Nephrology, Department of Medicine, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada.
² Division of Endocrinology, Department of Medicine, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada.
³ Boehringer Ingelheim Canada Ltd/Ltée, Burlington, Ontario, Canada.
⁴ Kidney Research Centre, Division of Nephrology, Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
⁵ Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.
⁶ Boehringer Ingelheim Norway KS, Asker, Norway.
⁷ Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut, USA.

PMID: 25360497
DOI: 10.1038/ki.2014.246

No abstract available

PubMed Disclaimer

Comment in

A nephrologist's point of view on sodium-glucose linked transporter-2 inhibitors: not all that glitters is gold.
Musetti C, Quaglia M, Stratta P. Musetti C, et al. Kidney Int. 2014 May;85(5):1243. doi: 10.1038/ki.2014.42. Kidney Int. 2014. PMID: 24786888 No abstract available.
The author replies.
Gilbert RE. Gilbert RE. Kidney Int. 2014 Nov;86(5):1058-9. doi: 10.1038/ki.2014.252. Kidney Int. 2014. PMID: 25360498 No abstract available.
The authors reply.
Musetti C, Quaglia M, Stratta P. Musetti C, et al. Kidney Int. 2014 Nov;86(5):1058. doi: 10.1038/ki.2014.251. Kidney Int. 2014. PMID: 25360499 No abstract available.

Comment on

Sodium-glucose linked transporter-2 inhibitors: potential for renoprotection beyond blood glucose lowering?
Gilbert RE. Gilbert RE. Kidney Int. 2014 Oct;86(4):693-700. doi: 10.1038/ki.2013.451. Epub 2013 Nov 20. Kidney Int. 2014. PMID: 24257692 Review.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

Grants and funding

Canadian Institutes of Health Research/Canada

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Sodium glucose cotransport-2 inhibition and intrarenal RAS activity in people with type 1 diabetes

Affiliations

Sodium glucose cotransport-2 inhibition and intrarenal RAS activity in people with type 1 diabetes

Authors

Affiliations

Comment in

Comment on

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical